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Guanylyl cyclase-activating proteins are EF-hand 
Ca2+-binding proteins that belong to the calmodulin su­
perfamily. They are involved in the regulation of photo­
receptor membrane-associated guanylyl cyclases that 
produce cGMP, a second messenger of vertebrate vision. 
Here, we investigated changes in GCAPl structure us­
ing mutagenesis, chemical modifications, and spectro­
scopic methods. Two Cys residues of GCAPl situated in 
spatially distinct regions of the N-terminal domain (po­
sitions 18 and 29) and two Cys residues located within 
the C-terminal lobe (positions 106 and 125) were em­
ployed to detect conformational changes upon Ca2+ 
binding. GCAPl mutants with only a single Cys residue 
at each of these positions, modified with iV^V'-dimethyl- 
JV-(iodoacetyl)-iV'-(7-nitrobenz-2-oxa-l,3-diazol-4-yl)eth- 
ylenediamine, an environmentally sensitive fluoro- 
phore, and with (l-oxy-2,2,5,5-tetramethylpyrroline-3- 
methyl)methanethiosulfonate, a spin label reagent, 
were studied using fluorescence and EPR spectroscopy, 
respectively. Only minor structural changes around 
Cys18, Cys29, Cys106, and Cys125 were observed as a func­
tion of Ca2+ concentration. No Ca2+-dependent oli­
gomerization of GCAPl was observed at physiologically 
relevant Ca2+ concentrations, in contrast to the obser­
vation reported by others for GCAP2. Based on these 
results and previous studies, we propose a photorecep­
tor activation model that assumes changes within the 
flexible central helix upon Ca2+ dissociation, causing 
relative reorientation of two structural domains con­
taining a pair of EF-hand motifs and thus switching its 
partner, guanylyl cyclase, from an inactive (or low ac­
tivity) to an active conformation.
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Changes in  intracellular [Ca2+] play a central role in the 
regulation of various physiological processes, either by the 
direct action of Ca2^ on effector enzymes, cation channels, and 
other proteins or, frequently, through processes m ediated by 
Ca2^-binding proteins. These proteins are grouped into specific 
subfamilies based on the ir sequence similarity, mode of Ca2^ 
coordination, physiological function, and tissue and cellular 
distribution. Several hundred distinct Ca2+-binding proteins 
have been identified, an observation consistent w ith unique 
and diverse roles of Ca2^ in  various cell types.
In recent years an interesting group of neuronal calcium- 
binding proteins (NCBP)1 (1, 2) (also known as neuronal cal­
cium sensors (3)) was discovered and characterized to varying 
degrees. B etter known members of th is family include recov­
erin (4^10), hippocalcin (11-13), neurocalcin (14^17), freque­
nin (18^22), visinin (23, 24), guanylyl cyclase-activating pro­
teins (GCAPs) 1^3 (2, 25), and guanylyl cyclase-inhibitory 
protein (26). NCBPs are 19-25-kDa proteins w ith four EF- 
hand motifs and are slightly larger than  CaM (—17 kDa). 
NCBPs and CaM have a sim ilar two-dimensional structure 
built around the EF-hand Ca2^-binding motifs, of which only 
two or th ree of four structu ra l EF-hand elements are functional 
in various NCBPs. The extensions of the N-term inal and C- 
term inal regions provide additional structu ra l elements dis­
tinct from CaM, and frequently these proteins are myristoy- 
lated a t the N term inus. The function of these proteins has 
been intensely scrutinized by several laboratories, w ith the 
most detailed insights being gained from studies on the regu­
lation of photoreceptor guanylyl cyclases (GCs) by GCAPs. In 
the dark (at high [Ca2^]), GC activity in the complex with 
GCAPs is low. Upon illum ination when [Ca2"] declines, GCAPs 
in the Ca2"-free form stim ulate GC activity up to 10-fold. This 
low [Ca2"] stim ulation of GCs is one of the key events in the 
restoration of the dark  sta te  of photoreceptor cells (2, 27, 28).
The structure of recoverin was the first to be determ ined in 
Ca2"-bound (9) and Ca2+-free forms (10, 29). In contrast to the 
two lobes of CaM and a central a-helix, recoverin contains a 
short U-shaped inter-dom ain linker th a t positions the two do-
1 The abbreviations used are: NCBP. neuronal calcium-binding pro­
tein; BTP, (1.3-bisltris(hydroxymethyl,)-methylaminoJpropane,l; CaM. 
calmodulin; DTNB. 5.5'-dithio(2-nitrobenzoic acid); EPR. electron p ara­
magnetic resonance; GC. guanylyl cyclase; GCAP. GC-activating pro­
tein; IANBD. A?.A?'-dimethyl-JV-(iodoacetylJ-A?'-(7-nitrobenz-2-oxa-1.3- 
diazol-4-ylJethylenediamine; MTSEA, 2-aminoethyl m ethanethio- 
sulfonate hydrobromide; MTSES. sodium (2-sulfonatoethyl) methane- 
thiosulfonate; MTSET, l2-(trimethylammonium,>ethylJmethanethiosul- 
fonate; MTSL, (l-oxy-2.2.5.5-tetramethylpyrroline-3-methyl,)methane- 
thiosulfonate; PAGE, polyacrylamide gel electrophoresis; RMSD. root 
m ean square deviation; ROS. rod outer segments.






















m ains in close contact w ith one another. This domain organi­
zation in recoverin produces a bi-lobed globular-shaped protein 
with pseudo C2 sym m etry th a t is significantly different from 
CaM. Consequently, the root m ean square deviation (RMSD) 
between the polypeptide chains of recoverin and CaM is —10 A. 
Although the binding of Ca2 " to recoverin produces a large 
rotation of the two lobes (RMSD = 9.6 A), the C-terminal 
domain rem ains mostly unchanged. By contrast, binding of 
Ca2 " to the EF2- and EF3-hand motifs causes a prom inent 
rearrangem ent of the N term inus and the extrusion of the 
N-term inal myristoyl group, term ed the Ca2 "-myristoyl 
switch, enabling recoverin to bind to m em branes a t high 
[Ca2 "]. In contrast to recoverin, which binds only two Ca2 " 
ions, frequenin binds th ree Ca2 " ions a t the EF2-, EF3-, and 
EF4-hand motifs (20, 21). The structural arrangem ents of this 
protein are sim ilar to those of neurocalcin and recoverin 
(RMSD = 1.3—1.7 A). Because of some changes in the orienta­
tion of one of the helices, frequenin contains a large hydropho­
bic crevice formed by 46 amino acids in the C-term inal lobe of 
unknown function (21). This protein has its myristoyl group 
exposed in both the Ca2 "-bound and -free forms (20). Neuro­
calcin is a closely related homolog of frequenin with three 
functional EF-hand motifs (17) but is a more distantly  related 
cousin to recoverin (RMSD = --3.2 A) and undergoes a confor­
m ational change sim ilar to the “Ca2 "-myristoyl switch” (17).
The structure of GCAP2 reveals th a t the four EF-hand mo­
tifs are arranged sim ilarly to recoverin (RMSD 2.2 A). GCAPl 
and GCAP3, however, have not been am enable to structura l 
studies, bu t based on computer predictions and biochemical 
studies, the EF-hand motifs can be assembled in three-dim en­
sional configurations sim ilar to GCAP2 but different from CaM 
and w ith the unique inhibitory role for the myristoyl group on 
GC a t high [Ca2 "] (2). Similarly to recoverin, the structure of 
GCAPl is significantly altered in response to Ca2 " binding as 
determ ined using fluorescence methods (30), change in mobil­
ity during SDS-PAGE (25, 31), and proteolytic susceptibility 
(32). Binding of Ca2 " converts GCAPl from an activator to an 
inhibitor of photoreceptor GC1 (32), with concomitant major 
conformational changes during th is transition. GCAPl is asso­
ciated w ith m em branes or w ith the particulate photoreceptor 
GCs a t low and high [Ca2 "] (31). The region around the EF3- 
hand motif, specifically T y r" , becomes significantly more ex­
posed to solvent in the Ca2 "-free form of GCAPl. Limited 
proteolysis studies also indicate th a t the N term inus is exposed 
in Ca2 "-bound and Ca2 "-free forms (32). Interestingly, a point 
m utation in T y r"  (Y99C) leads to the constitutive stim ulation 
of GC even a t high [Ca2 "]. This phenotype is thought to be 
associated w ith elevated levels of cGMP in cones and autoso­
mal dom inant cone dystrophy in one B ritish family (33-35).
GCAPl has four endogenous Cys residues a t positions 18, 29, 
106, and 125 suitable for specific chemical modifications. Here, 
we used site-directed m utagenesis of these residues in  combi­
nation w ith chemical modifications (Scheme 1) to examine the 
effect of Ca2 " binding on the stim ulation of photoreceptor GC 
by GCAPl. We also used fluorescence and EPR spectroscopies 
to examine the natu re  of the conformational changes in GCAPl 
and its m utants. We provide evidence th a t Ca2 " binding in­
duces m inor local changes around two C-term inal and N- 
term inal lobes, each containing two EF-hand motifs. In 
agreem ent w ith previous studies, we propose a photoreceptor 
GC activation model th a t  assum es changes w ith in  the  flexi­
ble cen tral helix of GCAPl, causing relative reorien tation  of 
two s tru c tu ra l dom ains and sw itching G CAPl from the active 
to the inactive state .
S ch em e 1. M o d ifica tio n s  o f  su lfh y d ry ls  u se d  in  th is  s tu d y . Up­
per linen, reaction schematics. R  and R ' depict various side chains 
linked to Cys. Below, chemical formulas of the  various reagents used.
EXPERIMENTAL PROCEDURES
GCAPl-HitSg Expression Vector and Site-directed Mutagenesis—The 
bovine GCAPl coding sequence was amplified by polymerase chain 
reaction with prim ers, which inserted a His„ tag  before the stop codon. 
The resulting fragm ent bGCAPl-His6 was cloned into pPCR-Script 
Amp SK(+,> (StratageneJ. The transfer vector pVLGCAPlHis was con­
structed bv subcloning a N otl-B am HI fragm ent into corresponding sites 
of the pVL1392 insect cell vector (BD Pharmingen,). The GCAPl m u­
tan ts  were generated with the QuikChange™  site-directed m utagene­
sis k it (StratageneJ. The single m utants were generated with 
pVLGCAPlHis as the tem plate. The prim ers used are listed in Table I: 
C18S-s/C18S-a for GCAP1(C18SJ, C29G-s/C29G-a for GCAP1(C29GJ, 
C29N/D-S and C29N/D-a for GCAP1(C29DJ and GCAP1(C29NJ, C29Y- 
s/C29Y-a for GCAP1(C29YJ, C1096-s/C106S-a for GCAP1(C106SJ, and 
C125S-s/C125S-a for GCAP1(C125SJ. Double m utants were generated 
by using DNA of GCAP1(C18SJ or GCAP1(C106SJ as tem plates, and 
triple m utan ts were generated bv using DNAs of double m utants as 
tem plate. The Cys-less G CA Pl2" m utan t GCAP1(C18S,C29N,C106S, 
C125SJ (GCAPl(c JJ was created using C29-GCAPl(c J DNA as the 
tem plate. The Ca21-insensitive bGCAPl(E75Q,ElllQ,E155Q,)-His6 
was created with a sim ilar approach, the prim ers used were E75Q-s/ 
E75Q-a, E ll lQ -s /E ll lQ -a ,  and E155Q-s/E155Q-a. The clones and 
DNA samples were isolated by standard  procedures, and the  entire 
coding frames of GCAPl and its m utan ts were verified by DNA 
sequencing.
Expression and Purification o f Bovine GCAPl-Hisg and Its M u­
tants—The baculovirus transfer vectors carrying GCAPl and its m u­
tan ts  were purified by Qiagen plasmid kits. High Five insect cells from 
cabbage looper were cotransfected with 0.25 /iig of BaculoGold (BD 
Pharmingen,) DNA and 5 /iig of transfer vector in 25-cm2 tissue culture 
flasks. After 4 days, the cells were harvested, pelleted, homogenized (in 
w ater containing protease inhibitor m ixture - Complete (Roche Molec­
u lar Biochemicals,I,I, and centrifuged (10 min a t 4000 x  g  a t 4 °CJ. The 
supernatan t containing GCAP1-His6 or its m utan ts was purified by 
Ni21 -nitrilotriacetic acid m etal affinity chromatography in nondenatur­
ing conditions according to the  m anufacturer’s protocol (Qiagen,). The 
proteins were purified to apparent homogeneity as determ ined by SDS- 
PAGE and Coomassie staining. In some experiments, GCAPl and its 
m utan ts were fu rther purified by gel filtration as described below.
GC Activity Assay—Fresh bovine eyes were obtained from a local 
slaughterhouse (Schenk Packing Company, Stanwood, WAJ. Washed 
ROS mem branes were prepared as described previously (36), reconsti­
tu ted  with recom binant GCAPs, and assayed as described by Otto-Bruc 
et al. (37,). [Ca211 was calculated using the computer program  Chelator 
1.00 (38,), and all assays were repeated a t least twice. Although some
2 GCAPl has four Cys residues in positions 18, 29, 106 and 125. 
GCAPl w ith m utation  of Cyslt< to Ser, Cys29 to Asn, Cys106 to Ser, and 
Cys12“ to Ser is denoted as GCAPl(c ,>. For sim plicity, the  trip le 
m u tan ts  w ith th e  Cvs th a t is preserved as in wild-tvpe GCAPl are 

















Ca2+-sensitive Regions o f GCAPl 43363
T a b l e  I
The list o f GCAPl mutagenesis primers
Name Sense Antisense
C18S 5'-CAGCACCGAGTCCCACCAGTGGTAC 5 -GTACCACTGGTGGGACTCGGTGCTG
C29S 5'-CATGACAGAGTCCCCCTCCGGCC 5 -GGCCGGAGGGGGACTCTGTCATG
C29G 5'-CATGACAGAGGGCCCCTCCGGCC 5 -GGCCGGAGGGGCCCTCTGTCATG
C29N & C29D 5'-CATGACAGAG(A/G)ACCCCTCCGG CC 5 -GGCCGGAGGGGT(T/C)CTCTGTCATG
C29Y 5'-CATGACAGAGTACCCCTCCGGCC 5 -GGCCGGAGGGGTACTCTGTCATG
C106S 5 -CGGCAACGGATCCATCGACCGCG AC 5 -GTCGCGGTCGATGGATCCGTTGCCG
C125S 5 -GCCATTAACCCCTCCAGCGACTCGACC 5 -GGTCGAGTCGCTGGAGGGGTTAATGGC
E75Q 5 -CATTGATTTCATGCAGTACGTGGC GG 5 -CCGCCACGTACTGCATGAAATCAATG
E111Q 5 -CGACCGCGACCAGCTGCTCACCA TC 5 -GATGGTGAGCAGCTGGTCGCGGTCG






data  are shown without standard  deviations, they are the averages of 
two determ inations. Sim ilar results were obtained from a t least three 
different sets of experiments performed in duplicate. As a consequence 
of the high sensitivity of the GC system, the absolute values of one 
series occasionally varied from another by 10-20%. bu t w ith preserva­
tion of the ratio between the activity of two different preparations (for 
example, m utan ts of GCAPl).
Modification o f GCAPl Sulfhydryl Groups—Typically. 0.5 ml of pro­
tein  (0.2 mg/ml) was dialyzed against 10 m M  Hepes. pH 7.5. and then  
treated  with a modifying reagent. MTSEA. MTSET. or MTSES 
(Anatrace) (stock solution was 50 m M  in 11,0; the final concentration in 
the sample was 100 /xM). The reaction was allowed to proceed for 30 min 
at room tem perature. Labeled protein was separated from nonreacted 
modifying reagents by dialysis or by Ni21 -nitrilotriacetic acid 
chromatography.
E llm an’s Assay for Determination o f Sulfhydryls—Ellm an’s reagent. 
5.5'-dithio(2-nitrobenzoic acid) (DTNB; Sigma), reacts w ith sulfhydryl 
groups under slightly alkaline conditions to release the chromogenic 
compound 5-thio-2-nitrobenzoate. which absorbs a t 412 nm w ith an 
absorption coefficient of 13.600 M 1 cm The reaction of DTNB with 
native and modified forms of GCAPl and its m utan ts was carried out 
either in 900 /.d of guanidine hydrochloride (final concentration. 4 M), 
pH 8.0. or in 900 /xl of 10 m M  BTP. pH 8.0. containing 100 m M  NaCl. 0.4 
m M  EDTA. and 156.25 /xM to 390.6 /xM CaCl2. The reaction was initiated 
by the addition of 50 /ill of DTNB solution (final concentration. 1.8 m M ). 
After spectrum  stabilization, the reaction was in itiated by the addition 
of 50 /ill of GCAPl. The increase in absorbance was directly proportional 
to the concentration of free sulfhydryl groups in solution. Protein con­
centration was determ ined using the Bradford method (39).
Fluorescent Labeling and Fluorescent Spectroscopy—Purified protein 
(0.6 mg/ml. 1 mg) was mixed with 2 /.d (100 m M ) of 1ANBD (Molecular 
Probe. Eugene. OR). After 2 h  of incubation a t room tem perature, the 
sample was ultracentrifuged (10 m in a t 100.000 x g  a t 4 °C) and loaded 
on a Ni21 -nitrilotriacetic acid column equilibrated with 50 m M  Tris/HCl. 
pH 8.0. and 300 m M  NaCl. Excess dye was removed by washing the 
column with the same buffer. Labeled protein was eluted from the 
column by 250 m M  imidazole in 50 m M  Tris/HCl. pH 8.0. and 300 m M  
NaCl. and protein was dialyzed against 50 m M  Hepes. pH 7.8. and 60 
m M  KC1. 20 m M  NaCl. and 10 m M  MgCl2. In sim ilar experiments. 
GCAPl m utan ts modified by IANBD were repurified by Ni21 -nitrilotri­
acetic acid chromatography as described above. Fluorescent m easure­
m ent of modified m utan ts was carried out on a PerkinElm er LS 50 B 
spectrofluorimeter using a 1 x  1-cm quartz cuvette. Emission spectra 
were recorded from 400 to 650 nm with excitation wavelength a t 480 
nm and 7.5-nm slit width. Spectra were determined in 50 m M  Hepes. pH 
7.8. and 60 m M  KC1. 20 m M  NaCl. 10 m M  MgCl2. 0.4 m M  EGTA. and 
156.25 or 390.6 /xM CaCl2. [Ca21 J,,.,,,, was calculated as noted previously. 
For IANBD. an extinction coefficient of 21.000 M 1 cm 1 a t 481 nm was 
used to determ ine the concentration and stoichiometry of modification.
Site-directed Spin Labeling and EPR Spectroscopy—Purified GCAPl 
m utan ts containing single Cys residues (typically -100 /xM) were incu­
bated with a 3-fold molar excess of the sulfhydryl-specific nitroxide spin 
label (l-oxy-2,2,5.5-tetramethylpyrroline-3-methyl) m ethanethiosulfo- 
nate (Scheme 1; gift from Prof. K. Hideg) overnight a t 4 °C in 50 m M  
Hepes. pH 7.8. 60 m M  KC1. 20 m M  NaCl. 10 m M  MgCl2. and 0.4 m M  
EGTA buffer. Unreacted spin label was removed by repeated washing 
with the sam e buffer in Microcon centrifugal filters (Millipore Corpo­
ration. Bedford. MA). EPR spectroscopy was carried out on a Varian 
E109 X-band spectrom eter fitted w ith a loop-gap resonator (40. 41). 
Protein samples of 6 /.d were contained in Pyrex capillaries. Spectra 
were recorded using a 2 mW incident microwave power and 100 kHz 
field modulation. Collision ra tes of spin labels w ith oxygen in air were
estim ated using the power sa turation  technique as described previously 
(42).
Gel Filtration—GCAPl or its m utan ts ( -0.3 mg/ml. 250 /xl) was 
loaded on Superdex 200 (Amersham Pharm acia Biotech), equilibrated 
with 10 m M  BTP. pH 7.5. and 150 m M  NaCl. 50 /xM CaCl2 a t a flow rate 
of 0.4 ml/min. In additional experiments, the CaCl2 concentration was
1 m M  or substituted by 1 m M  EDTA. Proteins were detected a t 280 nm.
0.4-ml fractions were collected by SDS-PAGE. and an aliquot from each 
fraction was examined for the GC stim ulatory (inhibitory) activity.
RESULTS
To obtain additional insight into the conformational changes 
of GCAPl upon Ca2 " binding, we employed highly specific 
chemical modifications of Cys residues in combination with 
m utagenesis, fluorescence, and EPR spectroscopy. Bovine 
GCAPl has four Cys residues. The first two, Cys18 and Cys29, 
are located a t the N -term inal region. The la st two are Cys106, 
which is a p art of EF3-hand motif, and Cys125, which is located 
in the C-term inal lobe (Fig. 1, A  and B). In the three-dim en­
sional model of GCAPl, based on the x-ray structure of Ca2 "­
bound form of recoverin and the NMR structure of GCAP2 (Fig. 
IB), these four Cys are located in different regions of the 
protein and thus are ideally suited for reporting local changes 
upon Ca2 " binding. Two residues, Cys29 and Cys106 are present 
in the acidic p art of GCAPl containing EF-hand loops, whereas 
Cys18 and Cys125 are projecting toward the opposite ends of 
GCAPl (Fig. IB). GCAPl does not contain disulfide groups. 
Only Cys29 is highly conserved among NCBPs, w ith the excep­
tion of GCAP3 (Fig. 1C). This suggests a special functional or 
structural role of Cys29 in  GCAPl and in corresponding posi­
tions of other NCBPs. O ur experience w ith bacterially ex­
pressed GCAPl w as th a t the protein is m arginally active or not 
active a t all; therefore more time-consuming insect cell expres­
sion w as required.
The S tru c tu ra l In tegrity  o f  G C A P l a n d  Its  M u ta n ts—Several 
complementary techniques were used to assess the properties 
and folding of GCAPl and its m utants. F irst, recombinant 
bovine GCAPl and all m utan ts w ith His6 tag  were purified to 
apparent homogeneity, employing m etal affinity chromatogra­
phy (see “Experim ental Procedures”). All purification proce­
dures and preparation of ROS m em branes were previously 
reported (1, 30-33, 37, 43, 44, 46-51). Addition of the His6 tag 
to the C-term inal region did not affect the GC-stim ulating 
property of GCAPl as compared w ith native GCAPl (32). Sec­
ond, the extent of m yristoylation of recom binant GCAPl was 
m easured as described previously (33). Briefly, myristoylated 
GCAPl and its m utan ts (identified by radioactive labeling em­
ploying [3H]myristic acid) have slightly faster mobility than  
unm yristoylated GCAPl during SDS-PAGE (37). Q uantitative 
evaluation by scintillation counting and protein determ ination 
revealed th a t GCAPl and two other m utan ts were 70-91%  
acylated (33). All m utan ts show a sim ilar degree of acylation as 
judged by SDS-PAGE (Fig. 2A). Third, intrinsic fluorescence 






















F i g .  1. T h e  p o s it io n s  o f  C ys re s id u e s  in  th e  p r im a ry  a n d  th re e -d im e n s io n a l s t r u c tu r e s  o f  G C A Pl. A, the location of Cys residues in the 
prim ary sequence of GCAPl relative to Ca2 1 loops. Ca21 ions are m arked in yellow, and the  T y r"  residue th a t has been shown to be associated 
with the autosomal dom inant cone dystrophy when m utated  to Cys (34,) is shown in blue. The E F l-hand  m otif is nonfunctional in Ca21 binding 
because of a  lack of key residues im portant for the  Ca21 coordination. B. micro-environments of four Cys residues in native GCAPl. The ribbon 
representation of the protein is colored as follows: EF1- through EF4-hand motifs are in  gray, and wild-type Cys residues are in green /  yellow. The 
helices are num bered from the N to the  C term inus and are rainbow colored. The model was generated based on the basis of the crystal structure 
of unm yristoylated recoverin (Protein D ata Bank entry  1REC; Ref. 9) as described previously (30). Superposition of the  structures from th is group 
of Ca21 -binding proteins showed th a t the  m ain chain atoms of unm yristoylated. Ca21 -bound GCAP2. recoverin. and neurocalcin fold into a  sim ilar 
structure. The root m ean square deviation of the  m ain chain atom s (in the EF-hand motifs) is 2.2 A in comparing GCAP2 to recoverin and 2.0 A 
in comparing GCAP2 to neurocalcin. C. sequence alignm ent of hGCAPl. hGCAP3. hGCAP2. hGCAPl. fGClP. hRec. and hCaM. The Cys residues 
in GCAPl and in  other Ca21 -binding proteins are shown on a yellow background. Functional EF-hand motifs in GCAPl and other proteins are 
shown in blue. E F l-hand  m otif is onlv functional in CaM. The accession num bers for Ca21-binding proteins are given in parentheses: hGCAPl 
(NP_000400). hGCAP3 (AAD19944). hGCAP2 (AF173229). fGClP (AAC15878). hRec (NP_002894). hCaM (AC006536). and hFREQ (AF186409).
m utants as described previously (30). An example of fluores­
cence changes are shown for GCAPl and C18-GCAPl(c~) in 
Fig. 2B. All other m utan ts showed sim ilar changes, suggesting 
th a t the structural in tegrity  was preserved when the exposed 
Cys18, Cys106, and Cys125 and the buried Cys29 were replaced 
by Ser. Fourth, all GCAPs were extensively tested for the GC 
stim ulation a t low [Ca2+] (30 i i m )  and GC inhibition a t high 
[Ca2+] (1 /am). All active m utan ts were tested for GC stim ula­
tion as a function of [Ca2+] (for example, see Fig. 3A). These are 
sensitive assays th a t most likely would discrim inate between 
different forms of GCAPl as presented below. Fifth, all m u­
tan ts  competed w ith the constitutively active triple m utan t 
GCAP1(E75Q,E111Q,E155Q) (32) a t high [Ca2+] (Fig. 2 0 ,  sug­
gesting th a t the sites of GCAPl m utan ts binding to GC are 
preserved and unchanged. Sixth, conformational changes in 
GCAPl were m easured as a function of [Ca2+] employing lim­
ited proteolysis (32). Each m u tan t was tested under these 
conditions, and common sets of proteolytic products were gen­
erated a t low [Ca2+] (30 i im )  and a t high [Ca2+] (Fig. 2D). 
Seventh, therm al stability of the m utan ts was unaltered (Fig. 
2E), suggesting th a t the ir susceptibilities to hea t are not mod­
ified as a consequence of m utations. Taken together, these 
extensive characterizations of GCAPl and m utan ts indicate 
close sim ilarity in  overall structural properties for the wild- 
type GCAPl and its m utants.
S ing le  Cys M u ta n ts  o f  G C A P l—Because GCAPl has endog­
enous Cys residues a t positions 18, 29, 106, and 125, th ree of 
four of these residues were elim inated by m utagenesis to study 
chemical reactivity of the individual Cys residues. F irst, Cys 
residues were individually m utated  to Ser residues, which are 
nonreactive w ith Cys reagents. Single m utan ts of GCAPl 
(C18S, C106S, and C125S), in  which the Cys residue is replaced 
by Ser, are almost fully active (Table II), are expressed a t high 
or m oderate levels, and have Ca2+-dependent properties in 
stim ulation and inhibition of photoreceptor GCs indistinguish­
able from native GCAPl (data not shown). GCAP1(C29S) is 
inactive a t low [Ca2+], suggesting th a t Ser a t th is position 
could be detrim ental for proper folding of GCAPl into an active 
conformation. To te st w hether th is m u tan t binds to GCs, we 
stim ulated GC w ith native GCAPl a t low [Ca2+] (Fig. 3A) or 
w ith the triple m u tan t GCAP1(E75Q,E111Q,E155Q) a t high 






















Fig. 2. C h a ra c te r iz a tio n  o f G C A Pl a n d  i ts  m u ta n ts .  A, SDS-PAGE of GCAPl (a) and most extensively used m utan ts in th is studv, 
C18-GCAPl(c J (6J, C29-GCAPl(c ) (c), C106-GCAPl(c ) id), C125-GCAPl(c ) ie), and C29S-GCAP1 (/). Sim ilar electrophoretic p a tte rns were 
observed for other m utants. B, fluorescence emission spectra of GCAPl and C18-GCAPl(c ). Fluorescence spectra (30,i were m easured as a  function 
of fCa2 11, from 10 10 M isolid line) and a t fCa2 '1 = 10 8 M ired dashed line: fCa211 chosen as in Fig. 3). The emission spectra of GCAPl and the 
m utan t were recorded using Aox = 280 nm. There is no significant change in  spectral shape for GCAPl and C18-GCAPl(c ), both a t  2 /j,m and a t 
any fCa211. Similarly, all o ther m utan ts showed only m inor changes in their intrinsic fluorescence. The fluorescence titra tion  was reproducible in 
two independent experim ents for each m utant. C, competition assay of GCAPl and m utan ts GCAP1(E75Q,E111Q,E155Q)(32) a t high fCa211. The 
GC activity was m easured using washed ROS (a) in the presence of the constitutively active m utan ts (1 /u.g) a t 2 /j,m fCa2ll (6), and the presence 
of GCAPl (c) (2  /j,g) and most extensively used m utan ts in th is studv, C18-GCAPl(c ) (d )  (2  /j,g for th is and other m utants), C29-GCAPl(c ) (e), 
C106-GCAPl(c J (/), and C125-GCAPl(c ) (g). D, lim ited proteolysis of GCAPl and C29-GCAP(c ) by tiypsin. The digestion was carried out a t 
30 °C a t a  ratio of GCA Pls/trypsin 300:1, and the digest was analyzed by SDS-PAGE a t 5 min (lanes 1 and 5), 10 m in (lanes 2 and 6), and 16 min 
(lanes 3 and 7). +Ca2 ' represents 2 /u.M fCa2 ll, and -C 'a2 ' ind ica tes3 0  n M  fCa2 ll- Lane 4 represents undigested GCAP. All o ther m utan ts 
displayed sim ilar digestion patterns, although the varied levels of the proteolytic fragm ents resulted from different am ount of GCAPl m utan ts in 
the assay. E, stability of GCAPl and its m utants. The GC activity was m easured using washed ROS as a  source of GC (a) in  the presence of 0.5 
f i g  of GCAPl (c )  a t 30 n M  fCa211. The black bar represents GCAP not exposed to heat trea tm en t (open bar and gray bar), GCAPl preincubated for 
15 min a t 50 °C or 100 °C, respectively. O ther m utan ts C18-GCAPl(c ) id), C29-GCAPl(c ) (e), C106-GCAPl(c ) (/), and C125-GCAPl(c ) (g) were 
treated  in the sim ilar conditions. The varied levels of the GC stim ulating activity resulted from different am ounts of GCAPl m utan ts in the assays.
functional EF-hand motifs donating two oxygen atoms for the 
Ca2+ coordination from the last position of the binding loop and 
m utations to Gin disable the Ca2+ chelation. In both cases the 
m u tan t GCAP1(C29S) competitively inhibited GC stim ulation 
by active forms of GCAPl. These results suggest th a t 
GCAP1(C29S) binds to GCs but is unable to undergo the con­
formational changes th a t will transform  the m utan t from an 
inhibitory to an activated form.
To explore w hether the Cys29 to Ser m utation specifically 
prevented th is transform ation, additional m utan ts were pro­
duced (Table II). Cys29 was replaced by (i) a sm aller flexible 
Gly, (ii) sim ilar size charged and uncharged Asp or Asn resi­
dues, respectively, th a t support hydrogen bonding sim ilar to 
the Cys residue, and (iii) a  Tyr residue found in GCAP3 in the 
same position (Fig. 1C). Similar to GCAPKC29S), GCAPKC29G) 
and GCAP1(C29D) were also inactive, w hereas expression of 
GCAPKC29N) and GCAPKC29Y) yielded a m u tan t protein, 
albeit a t low yields, th a t activated photoreceptor GC a t low
[Ca2+] and inhibited a t high [Ca2+] (Fig. 3A ) resembling native 
GCAPl. In summ ary, these results suggest th a t Cys29 is lo­
cated in a region of GCAPl th a t is essential for the GC stim u­
lation a t low [Ca2+], although th is  residue is dispensable for 
GCAPl activity and can be substituted by Asn and Tyr. The 
Ca2+ titra tion  curve for GCAPKC29N) is sim ilar to GCAPl; 
therefore th is substitution was used in  the m ultiple Cys m u­
ta n ts  described below.
Double a n d  Triple Cys M u ta n ts  o f  G C A P l—A combination of 
double m utan ts GCAP1(C18S,C106S) and GCAPKC18S, 
C125S) produced active proteins (Table II). GCAPl triple m u­
ta n ts  C18-GCAPl(c~), C106-GCAPl(c~), and C125-GCAP1(C-) 
(with the C29N substitution in all and only one free Cys a t 
positions 18, 106, and 125, respectively) were also active and 
displayed activating properties of photoreceptor GC a t low 
[Ca2+] and inhibitory a t high [Ca2+] like native GCAPl (Fig. 
3B ). Cys-less GCAPl (GCAPlCc")) was expressed a t much 
















43366 Ca2+-sensitive Regions o f GCAPl
Fig. 3. Ca2+-dependent GC stimulatory activities of single and triple Cys mutants of GCAPl. A, Ca2* -dependent ROS GC stim ulatory 
activities of GCAPl (• ) ,  GCAP1(C29N) (O), and GCAP1(C29Y) (▼). GCAP1(C29S) (■) was inactive. Inset, competition of GCAP1(C29S) with 
Ca2*-insensitive GCAPl m utan t GCAP1(E75Q,E111Q,E155Q) a t 2 /lim lCa2*J£i,ee The gray bar represents the  range of GCAPKE75Q, 
E111Q,E155Q) reference activity alone. The m easurem ents were done in triplicate in these independent experiments, and the  difference between 
them  in IC50 did not vary more than  50 nM lCa2*J. B, Ca2*-dependent GC stim ulatory effects of trip le m utants containing one Cys a t positions 18,
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not shown). Introduction of a  positive (GCAPl m u tan t modified 
w ith MTSET) or a negative charge (modified w ith MTSES) in 
all of these positions individually generated the GCAPl prod­
ucts w ith significantly decreased (2-4-fold) GC stim ulating 
activity (Table III), which could be restored by the addition of 
dithiothreitol. These results suggest th a t modifications with 
MTSET or MTSES in GCAPl leads to alteration in the prop­
erties of GCAPl, for example in the interaction w ith photore­
ceptor GCs.
M odification  o f  Cys29^ C29-GCAPl(c~) stim ulated photore­
ceptor GCs a t low [Ca2+] and inhibited the cyclase a t high 
[Ca2^] (Fig. 4A). When compared w ith other triple m utants, 
modification of Cys29 appears to be the least quantitative with 
the rapidly reacting MTSET reagent (Scheme 1), as observed 
for C29-GCAPl(c~) (Table III). H igher concentrations of the 
reagent were required in comparison w ith other m utants, and 
inactivation of GCAPl m utan t was fully reversible w ith dithi­
othreitol (Fig. 4B). Hydrophobic modifications, such as DTNB 
or vinylpyridine of th is GCAPl m utan t did not cause inactiva­
tion. Im portantly, the in itial rates of DTNB modification of 
single Cys-containing GCAPl m utan ts showed no differences 
a t low and high [Ca2+] (data not shown), suggesting minor 
conformational changes around these Cys residues as a conse­
quence of Ca2^ coordination.
Fluorescence Spectroscopy—The environm entally sensitive, 
sulfhydryl-reactive, fluorescent JV^V'-dimethyl-iV-(iodoacetyl)- 
JV'-(7-nitrobenz-2-oxa-l,3-diazol-4-yl)ethylene-diamine (IANBD) 
(52-73) was used to monitor conformational changes in GCAPl 
m utants th a t occur upon addition of Ca2^ (Scheme 1). For exam­
ple, C18-GCAPl(c~) was modified by INABD quantitatively as 
determined by UV spectroscopy (Fig. 5A, inset). When excited by 
480-nm light, C18-GCAPl(c~)-IANBD emitted a t Aem = 530 nm. 
Changes in fluorescence were <10% for [Ca2^ ] ranging from 
10~8 to 10~6 m  with EC50 = 230 d m  (Fig. 5A, left and right 
panels), reversible upon addition of EGTA (data not shown), and 
did not cause a shift in Amax of the emission (right panel, inset). 
The quenching of the fluorescence by KI (0-250 m M ) was indis­
tinguishable for the C18-GCAPl(c~)-IANBD in the presence and 
the absence of Ca2+ (data not shown). Together, these data sug­
gest th a t only minor conformational changes occur around this
T a b l e  II
Stim ulation and inhibition o f photoreceptors GCs by GCAPl and its 
Cys m utants







Single Cys m utants
GCAPl-control 920 ± 120 + H
GCAPHC18S) 955 ± 90 + H
GCAPHC29S) 0 + L
GCAPHC29N) 810 ± 150 + L
GCAPKC29G) 0 + M
GCAPKC29Y) 815 ± 140 + M
GCAPKC29D) 0 + L
GCAPKC106S) 995 ± 90 + H
GCAPKC125S) 985 ± 70 + H
Double Cys m utants
GCAP1(C18S,C106S) 910 ± 80 + H
GCAP1(C18S,C125S) 855 ± 40 + M
Triple Cys m utants
C125-GCAPl(c-) 310 ± 120 - L
C106-GCAPl(c~) 520 ± 130 + H
C29-GCAPl(c-) 950 ± 210 + H
C18-GCAPl(c-) 705 ± 125 + M
Cys-less GCAPl m utant
'G C A Pl(c-) 310 ± 200 + L
' The maximal activity was measured a ts a tu ra tin g 4  /lim GCAPl (and
its m utants) a t 40 nM ICa2 . in the  experimental conditions of the
assay (“Experim ental Procedures"). The variations in the  maximal 
stim ulating activities reflect differences in the  intrinsic properties of 
GCAPls ra th e r than  in modified affinities for GCs.
b A qualitative comparison of th e  expression level GCAPl m utants. 
H, high 0 2 0 0  /ng of purified GCAPl or its m utants from 5 x  150-mm 
plate culture; M, moderate (50-200 jiig of purified GCAPl or its mu­
tan ts  from 5 x  150-mm plate culture; L, low (<50 /ng of purified GCAPl 
or its m utants from 5 x  150-mm plate culture). The expression of each 
m utant was reproduced a t least four times.
' A qualitative comparison of the  activity of GCAPl m utants meas­
ured in 1 /liM ICa2 + , inhibition; lack of inhibition.
region, including the N-terminal myristoyl group and nonfunc­
tional, disabled by natural mutations, the EF-1 hand motif.
The C29-GCAPl(c~)-IANBD m utan t was subjected to a sim ­
ilar analysis as the m utan t described above. Minor changes in 






















ever, the relative fluorescence intensity  was enhanced ~  4-fold 
a t Aem = 530 11111 as compared w ith C18-GCAPl(c_ )-IANBD 
(Fig. 5B) in all tested [Ca2"], suggesting immobilization or 
relocation of the LANBD group into a more hydrophobic envi­
ronm ent or both.3 C106-GCAPl(c_ )-IANBD decreased the in ­
tensity  of fluorescence only by —5% for [Ca2"] ranging from 
10~8 to 10~8 m w ith ECS0 = 280 iim ( Fig. 5C). Addition of Ca2" 
to C125-GCAPl(c_ )-IANBD increased the intensity  of fluores­
cence by -12% , bu t only a t the highest 10~8 m [Ca2"] (Fig. 5D). 
Together, these data suggest th a t regions of GCAPl around
a F urther increase in [Ca2+J to 5 mM led to additional increase of the 
fluorescence of C29-GCAPl(c~) by 76% (data not shown). This increase 
in fluorescence could result from oligomerization of the  GCAPl m utant 
in these nonphysiological conditions.
Table III
Determination o f free sulfhydryl groups in GCAPl and its m utants
GCAPl and mutants TKB“ GC activity'’ GC activity +DTT'’ "
nmol / nmol 
of protein
nmol/min nmol / min
GCAPl 4 0.19 ± 0.04 0.19 ± 0.03
GCAP1-MTSES 0.6 0.09 ± 0.02 0.21 ± 0.01
GCAP1-MTSET 0.7 0.09 ± 0.01 0.22 ± 0.01
C18-GCAPl(c~) 3.4 0.31 ± 0.03 0.31 ± 0.04
C18-GCAPl(c~)-MTSES 0 0.11 ± 0.01 0.24 ± 0.03
C18-GCAPl(c )-MTSET 0 0.12 ± 0.01 0.28 ± 0.02
C29-GCAPl(c~) 2.4 0.18 ± 0.04 0.19 ± 0.01
C29-GCAPl(c-)-MTSES 0.1 0.09 ± 0.01 0.16 ± 0.02
C29-GCAPl(c~)-MTSET 0.22 0.11 ± 0.03 0.21 ± 0.05
C106-GCAPl(c~) 2.2 0.36 ± 0.02 0.36 ± 0.02
C106-GCAPl(c-)-MTSES 0 0.08 ± 0.04 0.32 ± 0.02
C106-GCAPl(c~)-MTSET 0.02 0.13 ± 0.01 0.30 ± 0.04
C125-GCAPl(c~) 2.6 0.29 ± 0.06 0.29 ± 0.01
C125-GCAPl(c-)-MTSES 0 0.06 ± 0.02 0.23 ± 0.02
C125-GCAPl(c~)-MTSET 0 0.11 ± 0.03 0.38 ± 0.02
Cys29 and Cys108 undergo minor conformational changes th a t 
increase solvent exposure of these modified Cys residues. The 
region around Cys12° also undergoes m inor structural alter­
ations causing sequestration of the Cys-IANBD group into a 
more hydrophobic environm ent or slight immobilization of the 
fluorophore bu t only in  fully Ca2"-loaded GCAPl.
E P R  Spectroscopy—To investigate Ca2"-dependent changes 
in GCAPl, these same Cys m utan ts were modified w ith the 
spin label reagent MTSL to generate a spin labeled side chain 
(Scheme 1). A t low [Ca2"] ( [Ca2"]free = - 4 6  iim), the EPR 
spectral line shapes reflect a local structure entirely compatible 
w ith the structural model of GCAPl. According to the correla­
tion of EPR spectral line shapes and protein structure de­
scribed previously (74), the line shapes of both Cys12°- 
GCAPl(c~)-MTSL and Cys108-GCAPl(c^)-MTSL reflect a 
highly mobile side chain in agreem ent w ith the ir putative 
solvent-exposed locations w ithin the EF-hand loops. The line 
shape of the Cys29-GCAPl(c~)-MTSL spectrum  indicates a 
highly immobilized side chain in  a constrained environment, as 
expected for a site packed between two helices. Finally, the line 
shape of Cys18-GCAPl(c~)-MTSL suggests a distribution of 
side chain dynamic modes, perhaps corresponding to multiple 
structural states of the N -term inal region in slow exchange on 
the EPR tim e scale.
Only minor changes were observed between the EPR spectra 
recorded a t 46 iim and —86 him [Ca2"]free when the nitroxide was 
located a t Cys18, Cys108, or Cys125 (Fig. 6). On the other hand, 
EPR spectra of GCAPl with the spin label a t Cys29 showed a 
striking spectral broadening and a concomitant intensity de­
crease in this same range of [Ca2"]fl.ee. This observation 
prompted us to investigate the full Ca2" titration curve for this
GCAPl m utant. Over the physiological range of [Ca (the
" DTNB (Ellman’s reagent) reacts with sulfhydryl groups of GCAPl 
and produces 5-thio-2-nitrobenzoate (TNB), which provides product 
with an extinction coefficient a t 412 nm of 13,600 m _ i cm-1 . The 
concentration of proteins was determined using Bradford method.
b GC assay was performed as described under “Experim ental Proce­
dures" in the  presence or absence of 3 mM DTT. The activity is ex­
pressed in nmol of cGMP production per min.
activity profile is shown as a gray line in Fig. 7), only —8% change 
in spectral intensity was observed. Similar to observations made 
using fluorescence spectroscopy, further increases in [Ca2" ] ^  
led to a dramatic decrease in the spectral intensity in a titration­
like fashion centered around [Ca2"]free = ~1  him (Fig. 7).
In addition to the Ca2"-dependent change in EPR spectral 
line shape, the change in accessibility of the nitroxide a t posi­
tion 29 to collision w ith oxygen was also examined using the 
"Pi/., param eter (42). The value of "Pi/., is a direct m easure of
Fig. 4. Ca2+-dependent GC stim ulatory activity of C2f)-GCAPl(e ) and inactivation of the m utant by MTSET. A, Ca2+-dependent 
ROS GC activity stim ulated by GCAPl ( • )  and by C29-GCAPl(c~) (O). Inset, the  activity of GC without GCAPl (black bar), in the  presence of 
GCAPl (lightgray) and C29-GCAP1U: ) (dark gray) a t 40 nM and 1 ;lim [Ca2+J£i,ee. The m easurem ents were done in th ree  independent experiments, 
and the  difference between then in IC50 did not vary more than  80 nM [Ca2+J. B, the  activity of C29-GCAPl(c~) modified by the  increasing
•
under “Experim ental Procedures." The activity of ROS GC stim ulated by modified GCAPl was measured as described under “Experim ental 






















Fig. 5. F lu o re sc e n c e  p ro p e r t ie s  o f  G C A P l m u ta n ts  m o d ified  b y  IANBD. A, fluorescence emission spectra of C 18-G C A PK O  modified by 
IANBD as a function of increasing lCa2+Jfree (black a t lowest concentrations and red a t h ighest concentrations; A,,, = 480 nm). Inset, UV spectrum  
of modified O lS-GOAPlu: j m utant. Right panel, changes in fluorescence intensity as a function of lCa2+J£i.ee. Inset, difference in the  fluorescence 
intensity for C 18-G C A PK O  a t 40 nM  and 2 /j,m lCa2+J. B, lack of changes in the  fluorescence emission intensity of C29-GCAPl(c~)-INABD a t Aem 
= 530 nm as a function of lCa2+J£i.ee. C, fluorescence emission spectra of O lOB-GOAPlu: j modified by IANBD as a function of increasing lCa2+J£i.ee 
(black a t lowest concentrations and red a t highest concentrations; A.,, = 480 nm). Inset, changes in fluorescence intensity as a function of [Ca2 
I), fluorescence emission spectra of 0125-GOAP1 u: j modified by IANBD as a function of increasing [Ca2 (black a t lowest concentrations and 
red a t highest concentrations; A.,, = 480 nm). Inset, changes in fluorescence intensity as a function of [Ca2 I T h e  fluorescence m easurem ents 
were done in duplicate, and the  second se t of data  did not vary significantly from the set presented in th is figure.
solvent accessibility of the nitroxide and was found to decrease 
by a  factor of three upon an increase in  [Ca2+]free from 46 nM  to 
86 m M . Thus, the nitroxide is more deeply buried in the protein 
structure in the high [Ca2+] state.
Collectively, the above d a ta  show th a t there is very little 
change in  the secondary or te rtiary  structure in  the vicinity of 
spin labels upon physiological activation of GCAPl by Ca2+ but 
th a t a  second Ca2+-dependent event leads to a change in the 
environm ent around site 29 a t high nonphysiological [Ca2+] 
( > 1  m M ). The molecular origin of th is second process is u n ­
known bu t could possibly arise from oligomerization, perhaps 
aided by the relatively hydrophobic nitroxide group. However, 
because labels a t Cys18, Cys106, and Cys12° do not show sim ilar 
changes, the oligomer is likely to be a  nonspecific aggregate 
and m ay correspond to a dimer.
Gel F iltra tion—To investigate Ca2+-dependent oligomeriza­
tion of GCAPl, we used gel filtration m ethods a t high and low 
[Ca2+], In most cases, GCAPl and its m utan ts eluted (as shown 
in Fig. 8A, trace a) as a m ixture o f—80-90%  monomeric protein 






















Fig. 6. T h e  E P R  s p e c tra  o f  th e  t r ip le  G C A P l m u ta n ts  m o d ified  o n  a  s in g le  C ys re s id u e  w ith  M TSL in  th e  a b se n c e  a n d  th e  p re se n c e  
o f C aC l2. The proteins were modified, and the  spectra were recorded as described under “Experim ental Procedures.” The sam ples contained 30% 
sucrose in the  absence (46 nM ) or presence of ~86 m M  [Ca2
GCAPl is also monomeric (25). These resu lts  suggest th a t 
under physiological conditions GCAPl does not undergo C a2 h- 
dependent oligomerization.
DISCUSSION
R ela tionsh ip  between G C A P l, CaM, a n d  O ther N C B P —In 
vertebrate cells, Ca2 h is frequently coordinated by proteins 
containing the EF-hand motifs (75). Among the EF-hand-con- 
taining proteins, NCBPs have become targets for intense scru­
tiny because of the proven involvement and potential role of 
these proteins in key processes w ithin neurons (1-3). The to­
pology of NCBPs is sim ilar to th a t of CaM, consisting of a 
tandem  of two EF-hand motifs connected by the central helix 
and a pseudo 2-fold sym m etry (1, 76). The diversity of NCBPs 
is generated by the presence of unique amino acid sequences 
th a t produce distinct EF-hand pair positions and varying an­
gles between a-helices surrounding the EF-hand m otif (76). It 
has been proposed th a t these EF-hands display a constellation 
of unique conformational sta tes ( 77), which may be critical for 
precise tuning of target enzymatic activities in response to 
changes in [Ca2 hJ. GCAPs offer a special possibility to investi­
gate the conformational changes of these proteins, an opportu­
nity th a t is enhanced by the detailed characterization of the 
ta rge t enzyme, GC1. Therefore, a w ealth of information has 
accum ulated over the years (1, 2, 27, 78, 79).
Cys29 M uta tion  to A sn  a n d  Tyr, b u t N o t Ser, Gly, or Asp, 
Produced A ctive G C A P l—Of all Cys residues in GCAPl, Cys29 
appears to be the most sensitive to substitutions. The replace­
m ent of Cys29 by Ser, Gly, and Asp produced inactive proteins. 
Conversely, m utating  Cys29 to Tyr (present in GCAP3 a t this 
position) and Asn yielded active proteins. One possibility is 
th a t this site (region) is critically im portant for the conversion 
of the inactive Ca2 h bound form to the active Ca2 h form of
F ig. 7. P lo t  o f th e  r e la tiv e  c e n te r  l in e  h e ig h t  o f  C29- 
G C A P l(c” )-M TSL E P R  s p e c tra  a s  a  fu n c tio n  o f  [C a-i+]r,,.,.. The
decrease in the  relative am plitude of the  center line of each spectrum  is 
a result of the  changes seen upon addition of CaCl„ th a t leads to 
broadening of the  spectra. A typical Ca2 1 titra tion  of GCAPl-dependent 
stim ulation of GC activity is shown in black.
(Fig. 8B). Addition of 50 /xm Ca2 h did not affect th is ratio, 
although a t high [Ca2 h] additional am ounts of dimer (10-15%) 
were occasionally observed (data not shown). In less frequent 
preparations, the dimeric inactive form of GCAPl was observed 
a t levels up to —40% of the monomer (trace b ). Isolated peaks 
2 and 1 (trace b) w ere individually rechrom atographed a t low 
and high [Ca2hJ. There was no interconversion of one form 
into ano ther (trace c and d , respectively). Once more, there 
w as no C a2 h dependence on the  form ation of monomers/ 
dim ers under tested  conditions.4 I t is notew orthy th a t native























F ig .  8. G el f i l t r a t io n  p ro f ile  o f  G C A P l m u ta n ts . A, C106-GCAPl(c~) ( -0.3 mg/ml) was loaded on Superdex 200 (Amersham Pharm acia 
Biotech). The protein elution profile was monitored by absorption a t 280 nm (trace a). C29-GCAPl(c~) w as filtrated on Superdex 200 (Amersham 
Pharm acia Biotech) equilibrated w ith 10 m M  BTP, pH 7.5, 150 m M  NaCl, and 1 m M  EGTA (trace b). Peaks 1 and 2 were separately collected and 
filtrated on the  sam e column in the  presence of 50 /.iM CaCl„ (traces c and d) w ithout EGTA. The elution position of a GCAP fusion protein dimer 
is shown as a yellow arrow , carbonic anhydrase (29 kDa) is shown as a blue arrow , and cytochrome c (12.4 kDa) is shown as a red arrow. Black 
arrows show the elution of blue dextran (BD; molecular weight >  2,000,000) and NaN3. Inset, SDS-PAGE of molecular mass standards (s) (from 
the top, 92, 67, 43, 30, 21, and 14 kDa), peak 1 (lane 1), peak 2 (lane 2), and a covalent dimer of GCAPl (lane d) (A. Alekseev and K. Palczewski, 
unpublished observations). B, the GC activity in ROS measured in the  presence of peaks 1 and 2.
GCAPl or th a t this region is critical for the interaction with 
GC. In agreem ent w ith both possibilities GCAP1(C29S) is a 
potent competitor of a constitutively active GCAPl trip le m u­
ta n t but is unable to stim ulate GC a t low [Ca2"] (Fig. 2). 
However, this region does not undergo conformation changes 
upon Ca2" binding as shown by spectroscopic methods, sug­
gesting th a t the correct conformation of the N-term inal region 
is essential for the GC stim ulation.
Intriguingly, helix 2 and helix 3 form a hydrophobic cavity 
where Cys29 is located. Most likely the fluorescence probe is 
positioned along this cavity, where a hydrogen bond may be 
formed between Lys48 and a nitro  group of the IANBD moiety 
(Fig. 9, righ t panel). The spin label group may also intercalate 
into th is cavity. Consistent with th is model, Cys a t th is position 
can be modified by hydrophobic groups w ith retention of the GC 
stim ulatory activity. GCAPl modified by the fluorophore 
IANBD, whose emission properties are sensitive to the molec­
u lar environm ent and its accessibility to w ater (80), showed 
increased fluorescence as compared w ith other m utants. In a 
native state, a hydrogen bonding between Glu28 and Gin41 of 
GCAPl could be formed with GC (Fig. 9). In the Ca2"-bound 
form, Gly and Ser residues of the corresponding m utan ts are 
buried because Glu28, Glu38, and Gin41 come closer together 
and change the shape of the surface (Fig. 10). As shown in this 
study, th is region does not undergo major structu ra l changes as 
a function of Ca2". Therefore, we anticipate th a t the same 
interactions are still present in  a Ca2"-free state. In
GCAP1(C29N), Asn forms a hydrogen bond with Glu38, the 
sam e as Ser, but th is pair does not enter the interior of the 
protein. Surfaces for Asn and Asp look sim ilar; however, 
charged groups in this region prevent the activation of GC 
(Table III). Tyr29 of the GCAP1(C29Y) m u tan t is exposed and 
not covered by the Glu28-Gln41 pair. These modeling studies 
point to the possibility th a t the Cys29 region is involved in the 
interaction w ith GC th a t leads to increased cGMP production 
but perhaps is less im portant for the inhibition of GC activity 
a t high [Ca2"]. This hypothesis is consistent w ith the observa­
tion th a t the N-term inal region of GCAPl, including its my- 
ristoyl group, displays a different specificity in in teracting with 
GC, depending on the Ca2" coordination (37). In an independ­
en t study employing GCAP1/GCIP chimeric molecules, we fur­
the r dem onstrated the importance of the N-term inal region of 
GCAPl for GC stim ulation (81). Residues 1-43 of GCAPl (in­
cluding Cys29), replacing the corresponding residues in the 
inhibitory protein GCIP, converted a GC inhibitor into a GC 
activator.
Changes in the G C A P l S tructure  upon A d d itio n  o f  Ca2" — 
The results of this study are internally  consistent w ith previous 
investigations on the fluorescence spectra of native GCAPl and 
its Trp m utants, where Trp residues were specifically engi­
neered into regions of GCAPl to monitor Ca2" binding to 
EF-hand motifs (30). These studies suggested th a t during the 
transition  from inactive (Ca2"-bound) to active conformation 
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Fig. 9. T h e  m o d e l o f G C A Pl a ro u n d  
Cys29. The surface is color-coded. Blue. 
hydrophilic residues; red. hydrophobic 
residues; white. neu tra l residues. Cys29 is 
shown in vellouh The model was gener­
ated bv Insight II program  and minimized 
in c fK l force field (86. 87) together with 
the 5 A thick w ater layer. Homology mod­
eling was based on GCAP2 structure  (45). 
Hydrogen atoms were added a t pH 7.0. 
and the atomic charge assignm ent 
scheme of Gasteiger-M arsili (45) (left 
panel) was employed. Right panel, model 








IB) th a t causes an exposure of the hydrophobic residues of this 
helix. T y r"  is wedged between helix 6 and the EF3-hand motif 
(Fig. IS), and its m utation to Cys causes constitutive activation 
of the GCAPl m utant. The binding of Ca2" a t physiological 
conditions is insufficient to stabilize the m utan t GCAPl in  an 
inactive conformation. Thus, m u tan t GCAP1(Y99C) is consti­
tutively active, presum ably causing elevated levels of cGMP, in  
vitro  and in  vivo. These relatively subtle changes of cGMP 
levels are thought to be causative of autosomal dom inant cone 
dystrophy (33^35).
As shown in th is study, other regions of the protein undergo 
ra th e r minor conformational changes. These data  are also con­
sistent with lim ited proteolysis studies showing th a t in the 
Ca2"-bound form of GCAPl, the interior of the protein is pro­
tected from proteolytic degradation, whereas in the middle 
section of the protein is quickly cleaved the Ca2"-free form (32). 
Introduction of a hydrophobic group in the binding site of the 
pocket formed between helices 2 and 5 m ay make the modified 
protein prone to dimerization.
G C A P l versus GCAP2—Of the th ree GCAPs, GCAPl and 
GCAP2 have been the most intensely studied (2, 78). Surpris­
ingly, although GCAPl and GCAP2 stim ulate photoreceptor 
GCs, m any properties were reported to be different for both 
proteins. Like other Ca2"-binding proteins, GCAPl and 
GCAP2 are closely related evolutionarily, and the ir genes were 
generated by ancient gene duplication/inversion events, sim i­
la r to S-100 Ca2"-binding proteins (82); however, these two 
GCAPs share only —45% homology on the sequence level. 
GCAP2 is more soluble th an  GCAPl, and GCAP2 has been 
proposed to increase its solubility upon binding of Ca2" ions
(83). To our knowledge, it is the only known EF-hand-contain- 
ing protein to show such a property; typically, the opposite 
is more frequently observed. For example, using small angle 
x-ray scattering and circular dichroism, it was shown th a t the 
related protein recoverin aggregates in  the Ca2"-bound forms
(84) but is monomeric and soluble in the Ca2"-free form. De­
spite th is solubility property, GCAP2 inhibits GCs a t high 
[Ca2"] (83). Recoverin is monomeric and soluble in Ca2"-free 
form. GCAPl, in  contrast, is mostly associated with the mem­
branes and/or GC1 under all [Ca2"] (31). There are other dif­
ferences between both of these proteins, most notably the sites 
of the GC interaction and the GC specificity (2, 44, 48, 78). 
Thus, despite some sim ilarities between these two proteins and 
other members of NCBP, there are im portant fundam ental 
differences. This observation is surprising because the struc­
tures of all these proteins are predicted to be sim ilar (see the 
Introduction).
Fig. 10. T h e  m o d e l o f G C A Pl a ro u n d  p o s itio n  29. The surface is 
color-coded. Blue, hydrophilic residues; red, hydrophobic residues; 
ivhite, neu tra l residues. The residue in position 29 is shown in yellow. 
Com putational details are the same as those described in the Fig. 9 
legend. In position 29 the following residues are shown: Cys. Ser. Gly, 
Tyr. Asp. and Asn.
M odel o f  the A ctiva tion—It was recently proposed, based on 
gel filtration studies, th a t the Ca2"-loaded GCAP2 monomer 
undergoes reversible dimerization upon dissociation of Ca2"
(85). This observation was correlated w ith the ability of GCAP2 
to activate photoreceptor GC and its ability to dimerize a t low 
free [Ca2"]. Those conclusions are different from the results 
presented in th is study with GCAPl. These differences could 
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F ig. 11. M odel o f  th e  GC re g u la tio n
by  G C A Pl. In the presence of jim 
LCa2+Jfree GCAPl inhibits GC activity 
(left). It is still unclear, w hether an extra­
cellular (intradiscal) ligand regulates GC 
activity. Upon illumination, GCAPl 
causes change in the GC, increasing the 
enzymatic activity of cGMP production 
(right). In th is model, binding of Ca2+ to 
GCAPl does not cause dimerization, 








GCAPs, experimental conditions, or folding of proteins as a 
consequence of bacterially expressed proteins versus GCAPl 
expressed in insect cells. As shown in gel filtration experiments 
(Fig. 8), GCAPl does not undergo reversible Ca2 "-dependent 
changes in its aggregation sta tus, and the small fraction of 
GCAPl forming dimers is unable to stim ulate photoreceptor 
GCs. In addition, it was reported th a t native GCAPl, purified 
from the bovine retina, behaves as a monomer (25). These 
studies are consistent w ith fluorescent spectroscopy in this and 
a previous report (30) and w ith EPR spectroscopy th a t did not 
detect any major conformational changes or oligomerization.
The model for the GCAPl activation th a t is emerging is 
consistent with the one presented in Fig. 11. GCAPl forms a 
stable m ulti-site attachm ent complex with GC. During activa­
tion (lowering [Ca2 "J), GCAPl undergoes rotation around cen­
tral helix 6 (Fig. 1) th a t ultim ately leads to changes in the 
catalytic site of GC (47).
In summ ary, we utilized the sulfhydryl chemistry of GCAPl 
and its m utan ts to understand the conformational changes in 
the protein induced by Ca2 " binding. Four endogenous Cys 
residues a t positions 18, 29, 106, and 125 provide an excellent 
spatial distribution of these reporter residues to map Ca2 "­
induced conformational changes. Side-directed substitution of 
these amino acids did not perturb  the overall properties of 
GCAPl as tested  by various complementary methods. We dem­
onstrate th a t local changes around two C-terminal and N- 
term inal lobes, each containing two EF-hand motifs, are ra the r 
minor, suggesting th a t larger Ca2 "-dependent changes occur 
only w ithin the flexible central helix of GCAPl. We offer a 
model of a photoreceptor GC activation th a t assumes changes 
w ithin the flexible central helix of GCAPl cause relative reori­
entation of two structural domains, switching GCAPl from the 
active to the inactive state.
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